TRIM-ing Ligand Dependence in Castration-Resistant Prostate Cancer

5Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Prostate cancer is lethal when tumors evolve to activate androgen receptor signaling, which circumvents ligand-deprivation therapy. In this issue of Cancer Cell, Groner et al. show that histone reader and transcription co-regulator TRIM24 occupies a central role in this evolution, nominating inhibitors of TRIM24’s bromodomain as a new therapeutic avenue.

Cite

CITATION STYLE

APA

Patel, L. R., & Barton, M. C. (2016, June 13). TRIM-ing Ligand Dependence in Castration-Resistant Prostate Cancer. Cancer Cell. Cell Press. https://doi.org/10.1016/j.ccell.2016.05.014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free